Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 198.69

+2.0%

Dec 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jay silberman who wrote (3839)	6/28/1997 10:19:00 AM
From: Henry Niman	of 32384

jay, I missed the upgrade. If the data you posted is correct (and that is what it says in Barron's), then H&Q must have upgraded LGND from a BUY to a STRONG BUY (or they dropped coverage and someone else started coverage with a STRONG BUY). When Lehman Brothers re-initiated coverage of LGND with a BUY (equal to a STRONG BUY) their rating moved from 1.3 (3 STRONG BUYS and 1 BUY) to 1.2 (4 STRONG BUYS and 1 BUY). The First Call (as reported by Barron's) shows 5 STRONG BUYS which moves LGND into a tie for 11th place among all companies with 5 or more recs (and #1 among Biotechs). I can access Zacks and as of 6/21/97 LGND had 4 STRONG BUYS and 1 BUY. If H&Q upgraded to STRONG BUY, then they would be #1 for Biotechs according to Zacks also (Zacks doesn't have a minimum number of recs, so LGND was #24 because Zack's rates 1 or more STRONG BUYS, with no lower ratings, as higher than LGND's earlier listing of 4 STRONG BUYS and 1 BUY). Henry

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next